Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
102.37
-0.06 (-0.06%)
Jan 30, 2026, 11:46 AM EST - Market open
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $7.95 billion as of January 30, 2026. Its market cap has increased by 54.56% in one year.
Market Cap
7.95B
Enterprise Value
7.15B
1-Year Change
54.56%
Ranking
Category
Stock Price
$102.37
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $7.95B, an increase of 898.76%. That is a compound annual growth rate of 66.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 7.95B | 1.83% |
| Dec 31, 2025 | 7.81B | 40.44% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jazz Pharmaceuticals | 10.20B |
| Axsome Therapeutics | 9.48B |
| ABIVAX Société Anonyme | 9.41B |
| Arrowhead Pharmaceuticals | 9.37B |
| Praxis Precision Medicines | 8.73B |
| Halozyme Therapeutics | 8.26B |
| Krystal Biotech | 8.04B |
| Cytokinetics | 7.83B |